SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-075101
Filing Date
2011-08-09
Accepted
2011-08-09 16:20:44
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c18865e10vq.htm 10-Q 439768
2 EX-3.1 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION c18865exv3w1.htm EX-3.1 4692
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO c18865exv31w1.htm EX-31.1 5806
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO c18865exv31w2.htm EX-31.2 5791
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO c18865exv32w1.htm EX-32.1 3419
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO c18865exv32w2.htm EX-32.2 3407
  Complete submission text file 0000950123-11-075101.txt   1645472

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT idix-20110630.xml EX-101.INS 167321
8 EX-101 SCHEMA DOCUMENT idix-20110630.xsd EX-101.SCH 11802
9 EX-101 CALCULATION LINKBASE DOCUMENT idix-20110630_cal.xml EX-101.CAL 30163
10 EX-101 LABELS LINKBASE DOCUMENT idix-20110630_lab.xml EX-101.LAB 104508
11 EX-101 PRESENTATION LINKBASE DOCUMENT idix-20110630_pre.xml EX-101.PRE 63742
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 111021053
SIC: 2834 Pharmaceutical Preparations